(NYSE: NVST) Envista Holdings's forecast annual revenue growth rate of 1.38% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.84%.
Envista Holdings's revenue in 2024 is $2,533,600,000.On average, 7 Wall Street analysts forecast NVST's revenue for 2024 to be $429,504,548,357, with the lowest NVST revenue forecast at $428,195,871,179, and the highest NVST revenue forecast at $431,651,975,669. On average, 7 Wall Street analysts forecast NVST's revenue for 2025 to be $439,344,817,205, with the lowest NVST revenue forecast at $436,242,920,439, and the highest NVST revenue forecast at $449,248,877,832.
In 2026, NVST is forecast to generate $455,070,092,633 in revenue, with the lowest revenue forecast at $449,431,140,059 and the highest revenue forecast at $468,922,881,599.